GO
Loading...

Biotech breakdown?

Monday, 7 Apr 2014 | 5:43 PM ET

Dr, Yaron Werber, Citi Research managing director, looks at the valuation of the biotech sector. Dr. Weber finds large cap names more attractive than small and mid-cap stocks.